ATRC
AtriCure, Inc.$34.51+0.12 (+0.34%)Prev Close$34.32·MCap$1.74B·P/E—·Vol315.6K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
11
$1.71M
◆
Net Activity
Net Seller
$1.71M
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at AtriCure, Inc. (ATRC) has been exclusively selling, with 0 insider purchases totaling $0.00 and 11 insider sales totaling $1.71M. The most recent insider transaction was by Prange Karen (director), who sold $86.0K worth of shares on May 22, 2026. AtriCure, Inc. operates in the Healthcare sector, within the Medical - Instruments & Supplies industry, with a market cap of $1.74B.
ATRC Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | Prange Karen | director | Sell | 3,000 | $28.65 | $86.0K | 26,373 |
| May 18, 2026 | Doraiswamy Vinayak | officer: Chief Scientific Officer | Sell | 5,000 | $28.13 | $140.7K | 91,875 |
| Mar 16, 2026 | Doraiswamy Vinayak | officer: Chief Scientific Officer | Sell | 5,000 | $29.83 | $149.2K | 96,875 |
| Nov 26, 2025 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 5,166 | $37.29 | $192.6K | 0 |
| Nov 24, 2025 | WEHRWEIN SVEN | Director | Sell | 10,000 | $37.66 | $376.6K | 0 |
| Nov 21, 2025 | Yuen Maggie | Director | Sell | 3,000 | $35.72 | $107.2K | 0 |
| Sep 12, 2025 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 3,000 | $36.30 | $108.9K | 0 |
| Aug 22, 2025 | WEHRWEIN SVEN | Director | Sell | 5,000 | $37.00 | $185.0K | 0 |
| Aug 19, 2025 | WEHRWEIN SVEN | Director | Sell | 5,000 | $36.00 | $180.0K | 0 |
| Aug 6, 2025 | GROVES REGINA E | Director | Sell | 2,452 | $36.82 | $90.3K | 0 |
| Aug 5, 2025 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 2,500 | $36.58 | $91.5K | 0 |
| May 28, 2025 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 2,500 | $33.44 | $83.6K | 0 |
| Mar 5, 2025 | Prange Karen | Director | Sell | 6,100 | $38.12 | $232.5K | 0 |
| Mar 1, 2025 | CARREL MICHAEL H | President, CEO, & Director | Sell | 43,926 | $38.74 | $1.70M | 0 |
| Mar 1, 2025 | Dahlquist Karl S. | Chief Legal Officer | Sell | 9,870 | $38.74 | $382.4K | 0 |
| Mar 1, 2025 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 9,672 | $38.74 | $374.7K | 0 |
| Mar 1, 2025 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 9,673 | $38.74 | $374.7K | 0 |
| Mar 1, 2025 | Privitera Salvatore | Chief Technical Officer | Sell | 8,397 | $38.74 | $325.3K | 0 |
| Mar 1, 2025 | Seith Douglas J | Chief Operating Officer | Sell | 15,050 | $38.74 | $583.0K | 0 |
| Mar 1, 2025 | Wirick Angela L | Chief Financial Officer | Sell | 13,633 | $38.74 | $528.1K | 0 |
| Mar 1, 2025 | Yount Deborah Lee | Chief Human Resources Officer | Sell | 11,961 | $38.74 | $463.4K | 0 |
| Aug 15, 2024 | Yuen Maggie | Director | Sell | 3,500 | $24.07 | $84.2K | 0 |
| May 30, 2024 | Privitera Salvatore | Chief Technical Officer | Buy | 5,000 | $22.25 | $111.3K | 0 |
| May 1, 2024 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $24.09 | $36.1K | 0 |
| Apr 1, 2024 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $30.39 | $45.6K | 0 |
| Mar 18, 2024 | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,885 | $32.16 | $60.6K | 0 |
| Mar 12, 2024 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $36.72 | $55.1K | 0 |
| Mar 5, 2024 | Dahlquist Karl S. | Chief Legal Officer | Sell | 8,231 | $37.36 | $307.5K | 0 |
| Mar 1, 2024 | CARREL MICHAEL H | President, CEO, & Director | Sell | 47,824 | $36.28 | $1.74M | 0 |
| Mar 1, 2024 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 8,855 | $36.28 | $321.3K | 0 |
| Mar 1, 2024 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 8,856 | $36.28 | $321.3K | 0 |
| Mar 1, 2024 | Privitera Salvatore | Chief Technical Officer | Sell | 7,354 | $36.28 | $266.8K | 0 |
| Mar 1, 2024 | Seith Douglas J | Chief Operating Officer | Sell | 14,596 | $36.28 | $529.5K | 0 |
| Nov 1, 2023 | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,248 | $34.43 | $43.0K | 0 |
| Aug 6, 2023 | Wirick Angela L | Chief Financial Officer | Sell | 5,191 | $57.23 | $297.1K | 0 |
| Jul 26, 2023 | Dahlquist Karl S. | Chief Legal Officer | Sell | 3,417 | $57.09 | $195.1K | 0 |
| Jun 8, 2023 | Prange Karen | Director | Sell | 713 | $47.89 | $34.1K | 0 |
| Jun 6, 2023 | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,422 | $47.03 | $66.9K | 0 |
| Jun 1, 2023 | Yount Deborah Lee | Chief Human Resources Officer | Sell | 5,240 | $34.02 | $178.3K | 0 |
| May 26, 2023 | Yuen Maggie | Director | Sell | 4,313 | $47.04 | $202.9K | 0 |
| May 1, 2023 | Dahlquist Karl S. | Chief Legal Officer | Sell | 4,417 | $44.83 | $198.0K | 0 |
| Mar 1, 2023 | CARREL MICHAEL H | President, CEO, & Director | Sell | 45,470 | $38.81 | $1.76M | 0 |
| Mar 1, 2023 | Dahlquist Karl S. | Chief Legal Officer | Sell | 6,894 | $38.81 | $267.6K | 0 |
| Mar 1, 2023 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 4,793 | $38.81 | $186.0K | 0 |
| Mar 1, 2023 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 7,083 | $38.81 | $274.9K | 0 |
| Mar 1, 2023 | Privitera Salvatore | Chief Technical Officer | Sell | 6,314 | $38.81 | $245.0K | 0 |
| Mar 1, 2023 | Seith Douglas J | Chief Operating Officer | Sell | 11,687 | $38.81 | $453.6K | 0 |
| Mar 1, 2023 | Wirick Angela L | Chief Financial Officer | Sell | 3,532 | $38.81 | $137.1K | 0 |
| Sep 15, 2022 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 4,983 | $45.99 | $229.2K | 0 |
| Aug 6, 2022 | Wirick Angela L | Chief Financial Officer | Sell | 5,191 | $50.94 | $264.4K | 0 |
Showing 1–50 of 94
1 / 2
ATRC Insider Buying Activity
The following table shows recent insider purchases of AtriCure, Inc. (ATRC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 30, 2024 | Privitera Salvatore | Chief Technical Officer | Buy | 5,000 | $22.25 | $111.3K | 0 |
ATRC Insider Selling Activity
The following table shows recent insider sales of AtriCure, Inc. (ATRC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | Prange Karen | director | Sell | 3,000 | $28.65 | $86.0K | 26,373 |
| May 18, 2026 | Doraiswamy Vinayak | officer: Chief Scientific Officer | Sell | 5,000 | $28.13 | $140.7K | 91,875 |
| Mar 16, 2026 | Doraiswamy Vinayak | officer: Chief Scientific Officer | Sell | 5,000 | $29.83 | $149.2K | 96,875 |
| Nov 26, 2025 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 5,166 | $37.29 | $192.6K | 0 |
| Nov 24, 2025 | WEHRWEIN SVEN | Director | Sell | 10,000 | $37.66 | $376.6K | 0 |
| Nov 21, 2025 | Yuen Maggie | Director | Sell | 3,000 | $35.72 | $107.2K | 0 |
| Sep 12, 2025 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 3,000 | $36.30 | $108.9K | 0 |
| Aug 22, 2025 | WEHRWEIN SVEN | Director | Sell | 5,000 | $37.00 | $185.0K | 0 |
| Aug 19, 2025 | WEHRWEIN SVEN | Director | Sell | 5,000 | $36.00 | $180.0K | 0 |
| Aug 6, 2025 | GROVES REGINA E | Director | Sell | 2,452 | $36.82 | $90.3K | 0 |
| Aug 5, 2025 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 2,500 | $36.58 | $91.5K | 0 |
| May 28, 2025 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 2,500 | $33.44 | $83.6K | 0 |
| Mar 5, 2025 | Prange Karen | Director | Sell | 6,100 | $38.12 | $232.5K | 0 |
| Mar 1, 2025 | CARREL MICHAEL H | President, CEO, & Director | Sell | 43,926 | $38.74 | $1.70M | 0 |
| Mar 1, 2025 | Dahlquist Karl S. | Chief Legal Officer | Sell | 9,870 | $38.74 | $382.4K | 0 |
| Mar 1, 2025 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 9,672 | $38.74 | $374.7K | 0 |
| Mar 1, 2025 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 9,673 | $38.74 | $374.7K | 0 |
| Mar 1, 2025 | Privitera Salvatore | Chief Technical Officer | Sell | 8,397 | $38.74 | $325.3K | 0 |
| Mar 1, 2025 | Seith Douglas J | Chief Operating Officer | Sell | 15,050 | $38.74 | $583.0K | 0 |
| Mar 1, 2025 | Wirick Angela L | Chief Financial Officer | Sell | 13,633 | $38.74 | $528.1K | 0 |
| Mar 1, 2025 | Yount Deborah Lee | Chief Human Resources Officer | Sell | 11,961 | $38.74 | $463.4K | 0 |
| Aug 15, 2024 | Yuen Maggie | Director | Sell | 3,500 | $24.07 | $84.2K | 0 |
| May 1, 2024 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $24.09 | $36.1K | 0 |
| Apr 1, 2024 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $30.39 | $45.6K | 0 |
| Mar 18, 2024 | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,885 | $32.16 | $60.6K | 0 |
| Mar 12, 2024 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $36.72 | $55.1K | 0 |
| Mar 5, 2024 | Dahlquist Karl S. | Chief Legal Officer | Sell | 8,231 | $37.36 | $307.5K | 0 |
| Mar 1, 2024 | CARREL MICHAEL H | President, CEO, & Director | Sell | 47,824 | $36.28 | $1.74M | 0 |
| Mar 1, 2024 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 8,855 | $36.28 | $321.3K | 0 |
| Mar 1, 2024 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 8,856 | $36.28 | $321.3K | 0 |
| Mar 1, 2024 | Privitera Salvatore | Chief Technical Officer | Sell | 7,354 | $36.28 | $266.8K | 0 |
| Mar 1, 2024 | Seith Douglas J | Chief Operating Officer | Sell | 14,596 | $36.28 | $529.5K | 0 |
| Nov 1, 2023 | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,248 | $34.43 | $43.0K | 0 |
| Aug 6, 2023 | Wirick Angela L | Chief Financial Officer | Sell | 5,191 | $57.23 | $297.1K | 0 |
| Jul 26, 2023 | Dahlquist Karl S. | Chief Legal Officer | Sell | 3,417 | $57.09 | $195.1K | 0 |
| Jun 8, 2023 | Prange Karen | Director | Sell | 713 | $47.89 | $34.1K | 0 |
| Jun 6, 2023 | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,422 | $47.03 | $66.9K | 0 |
| Jun 1, 2023 | Yount Deborah Lee | Chief Human Resources Officer | Sell | 5,240 | $34.02 | $178.3K | 0 |
| May 26, 2023 | Yuen Maggie | Director | Sell | 4,313 | $47.04 | $202.9K | 0 |
| May 1, 2023 | Dahlquist Karl S. | Chief Legal Officer | Sell | 4,417 | $44.83 | $198.0K | 0 |
| Mar 1, 2023 | CARREL MICHAEL H | President, CEO, & Director | Sell | 45,470 | $38.81 | $1.76M | 0 |
| Mar 1, 2023 | Dahlquist Karl S. | Chief Legal Officer | Sell | 6,894 | $38.81 | $267.6K | 0 |
| Mar 1, 2023 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 4,793 | $38.81 | $186.0K | 0 |
| Mar 1, 2023 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 7,083 | $38.81 | $274.9K | 0 |
| Mar 1, 2023 | Privitera Salvatore | Chief Technical Officer | Sell | 6,314 | $38.81 | $245.0K | 0 |
| Mar 1, 2023 | Seith Douglas J | Chief Operating Officer | Sell | 11,687 | $38.81 | $453.6K | 0 |
| Mar 1, 2023 | Wirick Angela L | Chief Financial Officer | Sell | 3,532 | $38.81 | $137.1K | 0 |
| Sep 15, 2022 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 4,983 | $45.99 | $229.2K | 0 |
| Aug 6, 2022 | Wirick Angela L | Chief Financial Officer | Sell | 5,191 | $50.94 | $264.4K | 0 |
ATRC Insiders
Similar Stocks to ATRC
BDX
Becton, Dickinson and Company
$154.48+2.60%
$54.55B
MDLN
Medline Inc.
$39.23+1.54%
$34.08B
WST
West Pharmaceutical Services, Inc.
$358.05+0.11%
$24.99B
RGEN
Repligen Corporation
$147.63+0.34%
$8.14B
ATR
AptarGroup, Inc.
$129.10+0.64%
$8.01B
AVTR
Avantor, Inc.
$11.38+0.75%
$7.09B
MMSI
Merit Medical Systems, Inc.
$72.56+2.11%
$4.37B
ICUI
ICU Medical, Inc.
$158.43+3.35%
$3.94B